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INTRODUCTION 
The frequency of hospitalized patients who undergo 
some type of intravenous catheterization is very high, 
and on many occasions this is the main reason for 
hospital admission. A multicenter prevalence study 
carried out in Europe demonstrated that 63% of 
hospitalized patients had indwelling vascular devices 
[l]. The main complication of vascular catheterization 
is catheter-related infection (CRI), particularly catheter- 
related bacteremia (CRB). 
From 1986 to 1990 the National Nosocomial 
Infections Surveillance (NNIS) reported the rates of 
catheter-related bacteremias in the intensive care units 
(ICU) affiiated to this programme, according to their 
subspeciality [2]. This rate varied from 2.1 in respir- 
atory ICUs to 30.2 in burn units, per 1000 days of 
central venous catheterization. The rates of bacteremia 
associated with peripheral catheters were clearly 
inferior, varying between less than 1 .O in coronary care 
units or medical units, to 2.0 in traumatology ICUs, 
per 1000 days of catheterizatibn. 
PATHOGENESIS OF CATHETER-RELATED INFECTION 
There are different variables that influence the acquis- 
ition of catheter-related infection and/or bacteremia. 
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These include: (a)  the pathway of access of the micro- 
organisms; (b) host-related pathogenic factors; (c) intrinsic 
factors related to the different microbial species; and (d) 
the material used in the composition of the catheters. 
Microorganism's pathway of access 
The infection of an intravascular catheter takes place 
through one of these four mechanisms: 
Periluminal pathway: from the skin to the external 
surface of the catheter 
Intraluminal pathway: from the hub to the internal 
surface of the catheter 
Contaminated infusate: intraluminal seeding of the 
microorganism 
Hematogenous pathway: seeding of the catheter from 
another septic focus. 
The first two pathways are responsible for more than 
95% of the infections. 
Skin colonization and periluminal pathway 
The intravenous catheter elicits in the host a foreign 
body response producing a protein coat composed of 
fibronectin, laminin, collagen and especially fibrin, 
which is formed within the first 48-72 hours of 
insertion. 
Skin colonization with secondary spreading to the 
external surface of the catheter is the most common 
mechanism for catheter infection [3-51, mainly in 
short-term catheters, with a mean duration of 7-9 days 
[6-81. 
Hub colonization and intraluminal pathway 
The colonization of the hub usually occurs after routine 
manipulation and care of the catheter and, exception- 
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ally, by infusate contamination. It is an important 
mechanism of infection [9], especially in long-term 
catheters [lo]. In patients receiving total parenteral 
nutrition, 54-70% of catheter-associated bacteremias 
arise after colonization of the catheter connections 
[3,11,12]. Regardless of the time the catheter has been 
in place, some data suggest a more important role of 
the intraluminal pathway over the cutaneous mechan- 
ism in the pathogenesis of catheter-related bacteremias, 
since the percentage of bacteremias after catheter 
infection is far greater following intraluminal seeding 
than after periluminal infection [10,13]. 
Contamination of the infusate 
This is considered an exceptional cause of catheter- 
related infection. Some cases of intrinsic contamination 
during industrial manufacture of intravenous fluids 
have been reported, giving place to epidemic outbreaks 
of nosocomial bacteriemia [14-161. Much more 
frequently the infection takes place after manipulation 
of the infusate in the hospital (adding drugs to the 
solution, or adjusting the dose and dilution of the 
medication). The pathway of infection in this case is 
intraluminal, and the hub becomes infected in most 
cases [I 01. The most prevalent causative microorganisms 
are Gram-negative bacilli, especially Pseudomonas spp or 
Citrobacter spp, and less frequently bacteria of the group 
KES (Klebsiella spp, Enterobacter spp and Serratia 
spp), since they have the capacity to grow at room 
temperature, in physiologic saline and in isotonic 
glucose-based fluids. The lipid-based solutions used in 
parenteral nutrition can promote the growth of many 
bacteria and fungi, such as Cand ida  parapsilosis and 
M a l a s s e z i a f u $ w  [17,18]. Blood and blood components 
are more rarely contaminated due to the antibacterial 
properties of the blood itself, and to the low temper- 
atures of storage; there are, however, well described 
cases of infection due to bacteria capable of surviving 
under such low temperatures, like Yersinia enterocolitica; 
platelet concentrates carry the highest risk of infection, 
because of the longer time of storage 1191. 
Hematogenous seeding 
In this kind of infection the tip of the catheter becomes 
colonized after bacteremia arising from a distant focus 
of infection; the microorganisms survive and multiply 
protected by the fibrin coat of the external and internal 
surfaces of the tip which may be responsible for 
recurrent bacteremias despite adequate antimicrobial 
therapy [10,19]. 
Host-related pathogenic factors 
The intravascular catheter acts like a foreign body, 
leading to a host response that produces a fibrin layer 
that coats the whole surface of the indwelling catheter. 
This layer is rich in fibrin and fibronectin, two very 
adherent substances for S. aureus and Cand ida  spp [20]; 
both species also produce coagulase, taking advantage 
of the thrombogenic process that takes place in the 
catheter surface, and becoming firmly adhered to the 
monolayer. Coagulase-negative staphylococci (CNS) 
are capable of binding to fibronectin, but not to fibrin 
1201. 
Pathogenic issues related to the microorganisms 
The most representative phenomenon occurs with 
CNS, which have a high adhering capacity due to the 
production of a glycoprotein complex called slime. 
This substance protects the bacteria from the immune 
system response, and allows its growth 121,221. 
Other microorganisms like Pseudomonas aeruginosa 
and Cand ida  spp can produce similar substances, 
especially when they grow in rich glucose-based media 
[23,24]. 
Pathogenic factors related to the catheter material: 
Several in vitro studies have demonstrated that catheters 
made of polyvinyl chloride and polyethylene are more 
prone to bacterial adhesion that those of Teflon, 
elastomeric silicone or polyurethane [25]. The catheters 
with the lowest bacterial adhesiveness are those made 
of silicone, which are the most appropriate for long- 
term catheterization. 
DEFINITIONS AND DIAGNOSIS OF 
CATHETER-RELATED INFECTIONS 
The use of varying definitions in studies of catheter- 
related infections have made it difficult to compare 
existing studies of these infections. Diagnosis typically 
is based on clinical or laboratory criteria, with each 
having significant diagnostic limitations. Table 1 shows 
the definitions for catheter-related infection included 
in the last ‘Guidelines for Prevention of Intravascular 
Device-related Infections’ elaborated for the HICPAC 
(Hospital Infection Control Practices Advisory Com- 
mittee) [26]. 
Semiquantitative tip culture (>15 colony-forming 
units) by the roll-plate method [3], or quantitative 
culture (> lo3 colony-forming units) by flushing the 
catheter and then immersed in broth 1271, or placed in 
broth and sonicated 1281, are the cornerstones for 
diagnosis of C R I  in routine practice. However, there is 
a great deal of interest in alternative methods for 
diagnosing C R I  without catheter withdrawal, since 
treatment can be successfully completed with the 
infected device maintained in place. 
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Table 1 Definitions for catheter-related infection. 
Included in the last 'Guidelines for Prevention of 
Intravascular Device-related Infections' elaborated for the 
HICPAC (Hospital Infection Control Practices Advisory 
Colonized catheter 
Growth of > 15 colony-forming units (semiquantitative culture) 
or > lo3 (quantitative culture) from a proximal or distal catheter 
segment in the absence of accompanying clinical symptoms. 
Exit-site infection 
Erythema, tenderness, induration, or purulence wi thn  2 cm of 
the skin at the exit site of the catheter. 
Pocket infection 
Erythema and necrosis of the skin over the reservoir of a totally 
iniplantable device, or purulent exudare in the subcutaneous 
pocket containing the reservoir. 
Tunnel infection 
Erythema, tenderness, and induration in the tissues overlying the 
catheter and 2 cm from the exit site. 
Catheter-related bloodstream infection (CR-BSI) 
Isolation of the same organism ( ie .  identical species, 
antibiogram) from a semiquantitative or quantitative culture of a 
catheter segment and from the blood (preferably drawn from a 
peripheral vein) of a patient with accompanying clinical 
symptoms of BSI and no other apparent source of infection. In 
the absence of laboratory confirmation, defervescence after 
removal of an implicated catheter ifom a patient with BSI may 
be considered indirect evidence of CR-BSI. 
Infusate-related bloodstream infection 
Isolation of the same organism from infusate and from separate 
percutaneous blood cultures, with no other identifiable source of 
infection. 
Quantitative blood cultures 
Besides the diagnostic criteria for catheter-associated 
bacteremia shown in Table 1, the experience obtained 
from long-term catheters, where the intraluniinal 
pathway is more important than the periluminal 
mechanism, supports the role of paired quantitative 
blood cultures. This procedure is based on the 
demonstration that the number of microorganisms 
obtained through the catheter should be greater than 
that obtained through vein puncture, if the catheter is 
the source of the bacteremia. Two methods are used: 
pour plate agar dilution techniques or the lysis- 
centrifugation system. With some exceptions, most 
published studies have reported a specificity near 100% 
and sensitivities over 80% (Table 2). 
However, when blood cultures are negative and 
there is no evidence of bacteremia, the question is: 
which would be the correct way of dealing with a 
patient with an intravascular catheter and fever without 
any other probable focus of infection. The HICPAC 
Table 2 Paired quantitative blood cultures for the diagnosis 
of catheter-related bacteremia 
Author C a p d e ~ i l a ' ~ ~  Fanxo3 Moscaio4 PayaloS DouardIob 
Ratio 4 7 5 2 5 
Sensit. 94 78 100 47 88 
PPV 100 92 100 64 
Specif. 100 100 100 92 100 
Ratio: c.f.u. obtained through catheter / c.f.u. obtained through 
vein puncture. 
Sensit: Sensitivity; SpeciE Specificity; PPV Positive predictive value. 
consensus discourages the guidewire exchange of the 
catheter when there is evidence of infection; however, 
since many catheters are unnecessarily withdrawn 
because of unconfirmed suspicion of infection, this 
conservative approach could be recommended when 
there are doubts that the source of the infection is the 
catheter, and the new catheter should be withdrawn if 
cultures of the tip are positive. 
Skin and hub cultures 
Some authors, like Cercenado et al. [5] and Fan et al. 
[ 6 ] ,  reported rates of sensitivity and negative pre- 
dictive values over 90% with the combination of skin 
and hub semiquantitative cultures. Cultures of non- 
sterile areas, however, carry a substantial risk of false 
positive results, and the specificity and positive pre- 
dictive value of this approach are consequently below 
70%. A way of avoiding false positive isolates is to 
culture the subcutaneous part of the catheter; the 
catheter insertion site is properly disinfected first, and 
the catheter then pulled out 2-3 cm in order to 
expose the subcutaneous segment; a swab of this por- 
tion of the catheter is then cultured. With this method 
in combination with the culture of the hub, our group 
has reported rates of sensitivity and negative predictive 
values comparable with those obtained with con- 
ventional skin and hub cultures, but reaching higher 
rates of specificity and positive predictive values, above 
80% [29]. 
Based on molecular studies, some authors have 
recently questioned the role of skin and hub cultures as 
predictive of catheter distal tip colonization. Atela et al., 
using pulsed field gel electrophoresis, were able to 
recognize the presence of the same agent in both 
superficial cultures (skin and/or hub), and tip cultures, 
in less than one third of the colonized catheters they 
studied. Their explanation for this finding is that the 
superficial colonization may be a dynamic process [30]. 
On the other hand, some authors have confirmed by 
means of molecular diagnostic techniques the role of 
the superficial cultures in the pathogenesis of catheter- 
related infections [33]. 
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Rapid diagnostic techniques 
To avoid waiting for distal tip cultures, some studies 
have assessed the performance of catheter staining 
procedures that yield results in less than one hour. 
The two procedures that have been more extensively 
evaluated are the Gram and the acridine fluorescent 
stains. Although some authors have found a good 
correlation between these techniques and the culture of 
the tip, with sensitivity, specificity and negative 
predictive value over 85% [32-341, others have not 
corroborated these results, obtaining low sensitivity 
rates, and questioning these methods arguing that they 
are time consuming, require catheter withdrawal, and 
are not applicable to all types of catheters (in 10% of 
catheters these methods cannot be applied due to 
technical problems) [35,36]. 
Another interesting application of these techniques 
is the direct staining of blood obtained through the 
catheter. Applying a simple Gram stain to the undiluted 
and uncentrifuged blood drawn from 18 Hickman type 
catheters with associated bacteremia, Moonens et al. 
found a sensitivity of 6196, with a positive predictive 
value of 100% 1371. Similarly, in one study of 51 
children, the use of acridine stain after cytocentrifug- 
ation of the blood drawn through the catheter yielded 
rates of sensitivity and specificity of 87 and 9496, 
respectively [38]. 
lntraluminal brush 
The intraluminal brush has been designed as a metallic 
guidewire that is inserted through the hub and slips to 
the catheter tip. By means of a nylon brush incorpor- 
ated on the tip of the wire, the tip is brushed and then 
cultured, being rotated on agar plates in a similar way 
to the technique of Maki. The great advantage of this 
method is that it allows sanipling the tip of the catheter 
without withdrawal. Tighe compared the results 
obtained with this technique in 115 central vein 
catheters with those obtained with conventional tip 
cultures, with a sensitivity and specificity of 77% and 
100%, respectively, and with a sensitivity in the cases of 
confirmed bacteremia of 93% [39]. Nevertheless, 
brushing the tip of the catheter can produce spreading 
of bacteria to the bloodstream, triggering secondary 
bacteremias; this happened in 6% of the patients in this 
study, and that may carry serious complications. 
MANAGEMENT OF CATHETER-RELATED 
IN FECTlO N S 
I t  is easy to recommend the withdrawal of any infected 
catheter, an approach that is applicable to most non- 
tunnelled central venous catheters, whose replacement 
does not put the patient at a higher risk than that 
associated with an uncontrolled infection [40]. The 
problem arises in the case of indwelling tunnelled 
catheters and totally subcutaneous implanted ports; in 
this situation withdrawal of these devices may require 
anesthesia, administration of blood products, and can 
carry substantial discomfort to an otherwise frequently 
deteriorating patient. 
The attempt at conservative management of in- 
fected subcutaneous ports is less successful than using 
tunnelled Hickman type devices. Most authors re- 
commend the complete withdrawal of the infected 
implanted port, especially in the presence of evident 
inflammatory signs, a finding that seems to be the one 
that is best correlated with infection [41]. In the case 
of Hickman-type catheters, tunnel infections are 
usually serious and frequently lead to bacteremia, so 
there is little doubt about the necessity of withdrawal, 
irrespective of the causal agent. It is in the coninion 
cases of associated bacteremia without local clinical 
signs, that the management may favour a more con- 
servative approach with more likelihood of success. 
The responsible microorganism must be con- 
sidered when the option is maintaining the catheter. It  
is not acceptable in cases of infection due to yeasts, S. 
aureus, Gram-negative bacilli (especially Pseudomorias 
spp and Xantlzomonas spp), Bacillus spp and Couyrie- 
bactevitlnz JK  because of the high rates of relapses 
[41,42], far superior than those observed when the 
infection is caused by other agents, mainly CNS [43]. 
Whenever possible, it is advisable to administer 
antibiotic treatment through the catheter, using 
alternatively all the channels when a multilunien catheter 
is involved, in order to warrant a maximum exposure 
to the antimicrobial agent. The antibiotic-lock tech- 
nique has been developed as an attempt to obtain a 
more prolonged antimicrobial effect, sealing the channel 
of the catheter with an antibiotic solution. Preliminary 
experience with this approach is so favourable, even 
with some of the previously mentioned high-risk 
microorganisms, that it should be used in every case in 
which the catheter is not going to be removed 144-471. 
The antibiotics are added to the heparin solution that 
is applied after each use of the catheter. This antibiotic 
seal may make the systemic administration of antibiotics 
unnecessary beyond the strict control of the associated 
septic syndrome. The potential advantages of this 
technique are: (a) higher antibiotic concentrations in 
the catheter lumen; (6) lack of systemic antibiotic 
toxicity; (c) analytical monitoring of the patient is not 
necessary; ( d )  it reduces costs. The recommended doses 
have varied from 100 mg/L up to 5 mg/ml, and exceed 
several times the MIC of the bacteria, as well as the 
achievable serum levels obtained by systemic adminis- 
tration of the drugs. However, some studies carried out 
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in plastic surfaces have shown that some micro- 
organisms under these concentrations may develop 
tolerance (MBC >256 mg/L), suggesting that, given the 
absence of toxicity, the use of the higher doses may be 
recommended [46]. 
PREVENTIVE STRATEGIES 
Catheter infection arises as a result of the sum of several 
circumstances with different levels of importance in 
each individual case. The HICPAC consensus elabor- 
ated some guidelines for the correct handling of intra- 
vascular catheters, based on scientific evidence obtained 
from the medical literature, which are summarized in 
Tables 3 and 4 [26]. 
Infection risk factors 
Prolonged catheterization 
The duration of the catheter is one of the most 
important risk factors of infection. Despite this, the 
routine replacement of central vein lines is not recom- 
mended. If infection is suspected, the catheter may be 
replaced by means of a guidewire, and if the tip culture 
is positive the catheter must be removed [4&50]. 
Table 3 General recommendations for intravascular-device usezh 
1. Health care worker education and training (category IA) 
2. Surveillance for catheter-related infection 
2a Conduct surveillance (category IB) 
2b Palpate the catheter insertion site daily (category IB) 
2c Visually inspect the catheter insertion site daily (category IB) 
2d Remove the dressing and inspect daily (category 11) 
2e Record the date and time of catheter insertion (category IB) 
2f Do not routinely perform surveillance cultures (category IB) 
3. Handwashing before/after manipulating an intravascular device (category IA) 
4. Barrier precautions: Wear non-latex or latex gloves (category IB) 
5. Catheter insertion. Do not use cutdown procedures in insertion (category IA) 
6. Catheter site care 
6a Cutaneous antisepsis with 70% alcohol, 30% povidone-iodine or 2% tincture of iodine before catheter insertion 
(category 1A) 
6b When tincture of iodine is used, remove it with alcohol (category 11) 
6c Do not palpate the insertion site after the skin has been cleansed with the antiseptic (category 1A) 
6d Use either a sterdt: gauze or transparent dressing (category 1A) 
6e Replace catheter site dressing if it becomes damp, looqened or soiled (category IB) 
6f Avoid touching the catheter insertion site when the dressing is replaced (category 1A) 
7. Selection and replacement. Decisions regarding the type of device and its frequency of replacement should be determined on an 
individual patient basis (category IA) 
8. Replacement of administration sets and intravenous fluids. 
8a 
8b 
Replace IV tubing no more frequently than at 72-hour intervals, unless clinically indicated (category 1A) 
Replace tubing used to administer blood or lipid emulsions within 24 hours of initiating the infusion. 
9. Intravenous injection ports. Clean injection ports with 70% alcohol or povidone-iodine before accessing (category 1A) 
10. Preparation and quality control intravenous admixtures. 
10a Admix all parented fluids in the pharmacy in a laminar-flow hood using aseptic technique (category 1A) 
10b Check expiry date and turbidity (category 1A) 
1Oc Refrigerate multidose vials after they are opened (category 1A) 
11. Do not use filters routinely for infection control purposes (category 1A) 
12. Designate trained personnel for the insertion and maintenance (category 1B) 
13. Do not administer antimicrobials routinely before insertion or during use of an intravascular device to prevent infection 
(category 1B) 
Category IA. Strongly recommended for all hospitals and strongly supported by well-designed experimental or epidemiologic studies. 
Category IB. Strongly recommended for all hospitals and viewed as effective by experts in the field and a consensus of Hospital Infection 
Control Practices Advisory Committee (HICPAC), based on strong rationale and suggestive evidence, even though definitive scientific 
studies may not have been done. 
Category 11. Suggested for implementation in many hospitals. Recommendations may be supported by suggestive clinical or epidemiologic 
studies, a strong theoretical rationale, or definitive studies applicable to some, but not all, hospitals. 
No recommendation; unresolved issue. Practices for which insutficient evidence or consensus regarding efficacy exist. 
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Table 4 Recommendations for central venous catheters26 
1. Selection of catheter 
l a  Use a single-lumen central venous catheter (category 1B) 
l b  Use either a peripherally inserted central venous catheter, a tunneled catheter (e.g., Hickinan or Broviac), or an 
implantable vascular access device (i.e., port) for patients 4 years of age or older, in whom long-term vascular access (30 
days) is anticipated. Consider use of a totally implantable access device for younger pediatric patients (age <4) who require 
long-term vascular access (category IA) 
I n  adrrltr, consider use of a silver-impregnated collagen cuff or an antimicrobial- or antiseptic-impregnated central venout 
catheter if, after full adherence to other catheter infection control measures (e.g., maximal barrier precautions), there is still 
an unacceptably high rate of infection (category 11) 
1 c 
2. Selection of catheter insertion site. 
2a Weigh the risks and benefits (e.g.. pneumothorax, subclavian artery) (category IA) 
2b Use subclavian, rather than jugular or femoral, sites, unless medically contraindicated (category 1B) 
Barrier precautions. Use sterile technique, including sterile gown, gloves, masks, and large sterile drapes (category IB) 3.  
4. Replacement of catheter 
4a 
4b 
4c 
4d 
4e 
4f 
4g 
5. Cathetei 
5a 
5b 
SC 
Sd 
Se 
5f 
Do not routinely replace non-tunneled central venous catheters as a method to prevent catheter-related infections 
(category IA) 
No recommendation for the frequency of replacement of peripherally inserted central venous catheters. Unresolved issue 
No recommendation for frequency of replacement of totally implantable devices or the needles used to access them. 
Unresolved issue 
Replace pulmonary artery catheters at least every 5 days (category IB) 
If feasible, replace the arterial catheter introducer sheath every 5 days, even if the catheter has been removed (category IB) 
No recommendation for the reinoval of central catheters inserted under emergency conditions. Unresolved issue 
Guide wire exchange 
Use guide wire assisted catheter exchange to replace a malfunctioning catheter or to convert an existing catheter if there is 
no evidence of infection at the catheter site (category IB) 
Do not use guide wire assisted catheter exchange whenever catheter-related infection is documented (category IA) 
and catheter site care 
Do not use single-lumen parenteral nutrition catheters for purposes other than hyperalimentation (category IB) 
If a niultilumen catheter is used to admnister parenteral nutrition, designate one port for hyperalimentation (category 11) 
Wipe the catheter hub with an appropiate antiseptic (category IB) 
Routinely flush indwelling central venous catheters (e.g.. Hickman and Broviac) with an anticoagulant (category IB) 
110 not routinely apply antimicrobial ointment to central venous catheter insertion sites (category ID) 
Do not apply organic solvents (e.g.. acetone or ether) to the skin before insertion of parenteral nutrition catheters 
(category IA) 
See footnote Table 3. 
There are also doubts on the optimal periodicity of 
replacement of the infusion systems. Three studies 
demonstrated that a change every 72 hours is safe and 
economic [51-531. However, some infusates such as 
blood products and lipid-based fluids are more prone to 
contamination and, in these circumstances, the system 
must then be changed more frequently [15,54]. 
Composition of the catheter 
Flexible catheters made of silicone and polyurethane 
are less thrombogenic than those of polyvinyl chloride 
[55,56]. 
Number of lights 
Multi-lumen catheters have been associated with 
higher rates of infection than single-lumen devices in 
some series [57-591. However, other authors have not 
demonstrated this association [60]. 
Anatomical place 
Several studies have shown higher infection rates where 
catheters were inserted in the jugular vein, compared 
with those placed in the subclavian vein, with a relative 
risk of infection over 2,7 in some of them [61,62]. 
Another anatomic localization also associated with a 
higher infection risk is the femoral vein, due to the 
more intense bacterial colonization of the groin, and to 
the difficulty in keeping the area under aseptic con- 
ditions [63]. 
Parenteral nutrition 
Two meta-analyses have demonstrated in adult cancer 
patients that parenteral nutrition is intrinsically associ- 
ated with catheter infection [64,65]. This hazard has 
been calculated in children with cancer, with a relative 
risk 2.5 times greater than that for patients under the same 
conditions who do not receive parenteral nutrition [66]. 
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Go-morbidity 
In cancer patients with central vein catheters, neutro- 
penia is an independent risk factor associated with 
infection [67]. Recently, Tacconelli et al. have reported 
an association between the patient's basal condition, 
measured by the APACHE I1 score, and the risk of 
catheter-related sepsis [68]. 
Type of dressing 
A study carried out on 2000 peripherally inserted 
catheters failed to demonstrate differences in the 
number of infections between transparent-type 
dressings and those made of gauze [69]. Nevertheless, 
the results obtained in non-tunnelled central vein 
catheters seem to be different. A meta-analysis demon- 
strated higher colonization rates in catheters covered 
with transparent-type dressings, although the differ- 
ences in the rate of bacteremia were not significant 
between both groups [70]. 
Catheter handling 
The frequency of catheter manipulation is possibly the 
most important factor responsible for infection. Many 
of the previously mentioned factors influence the 
acquisition of infection since they cause more frequent 
manipulation of the catheter. 
Use of contaminated antiseptic solutions 
This should be an infi-equent situation at the present 
time. Improper disinfection policies such as conserva- 
tion of antiseptics in open lid containers have been an 
important cause of nosocomial infections in the past 
1711. 
Preventive factors 
Barrier precautions and intravenous therapy personnel. 
If maximal barrier precautions are used during CVC 
insertion, catheter contamination and subsequent 
CVC-related infections can be minimized, irrespective 
of whether the catheter is inserted in the operating 
room or at  the patient's bedside [72]. Available data 
suggest that personnel specially trained or designated 
with the responsibility for insertion and maintenance of 
intravascular devices provide a service that effectively 
reduces catheter-related infections and overall costs 
[731. 
Cutaneous antisepsis 
Maki et al. have demonstrated that clorhexidine is 
better than tincture of iodine or 70% alcohol in 
reducing catheter associated bacteremia [74]. Never- 
theless, another experimental study did not find 
significant differences among clorhexidine and 70% 
ethanol solutions as hub desinfectants [75]. In recent 
reports, the combined use of mupirocin and iodine 
solution has been shown to reduce jugular catheter 
colonizations in cardiac surgery procedures [76]. 
Silver coating 
In acutely ill patients, silver coating of short-term 
central venous catheters (mean: 5-9 days) [77,78] 
reduces the risk of infection; however, its efficacy in 
long-term catheters (mean: 20 days) [79] or Hickman 
devices has not been so evident [80]. 
Antibiotic coating 
Catheter coating with benzalconium chloride [81] or 
cefazolin [82] has been used successfdy. Maki et al., in 
a recent study of 403 central venous catheters, demon- 
strated a significant reduction in both colonization and 
catheter-related bacteremia using clorhexidine and 
silver sulfadiazine coated catheters 1831. Other authors 
have shown similar results with the same agents. How- 
ever, this procedure has not been efficient enough to 
prevent bacteremia in patients with parenteral nutrition 
and prolonged catheterizations [84]. Raad et al, have 
recently reported their experience with minocicline 
and rifampin coating, with reductions in colonization 
and bacteremia [85]. This coating has been considered 
by some authors as more bactericidal than clorhexidine 
or/and silver sulfadiazine coating [86]. 
Antimicrobial prophylaxis 
This should not be considered as recommended routine 
practice, although some studies [87,88], specially with 
glycopeptides [89,90], have shown its usefulness in 
reducing infections in some kinds of catheters. 
Tunnelling shon-term central venous catheters 
Randolph et al., in a recent meta-analysis, evaluated the 
efficacy of this approach [91]. Tunnelling decreased 
catheter-related colonization and catheter-related sepsis 
with bacteriological confirmation, but a single trial 
involving tunnelling of internal jugular catheters [92] 
accounted for the majority of this reduction. At the 
subclavian site, tunnelling showed a non-significant 
trend towards a reduced risk of catheter-related sepsis. 
In-line filters 
Commonly used in order to decrease the incidence of 
phlebitis, in-line filters have not shown a reduction in 
the rate of infection [93]. 
NOSOCOMIAL ENDOCARDITIS 
Infective endocarditis results after blood invasion of 
microorganisms which reach a susceptible endothelium. 
Spontaneous transient bacteremia is considered the 
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Table 5 Features of the most recent studies on nosoconiial endocarchis 
Reference Nosocomial/all Age > 60 Prosthetic valve Staphylococcal Mortality 
(Year) ("w ( % I 3  (%) ("/4 ('Xj 
Tarpenning y8 22/154 14/22 10/22 17/27 9/22 
1976-85 14.3% 63.6% 45.51% 77.4% 4 ).Y% 
Chen" 30/178 16/30 5/30 18/30 12/30 
1979-9 1 17% 53% 17% 60% 4OY" 
Fer~iandez-Guerrrro~~ 23/248 13/73 4/19 13/23 13/23 
Total 12.9% 57.3% 26.7'41 64% 45.3% 
NU: Not described 
1978-92 9.3% 56.5% 21% 56.596 56.5"b 
most frequent cause of this disease; however, epidemio- 
logical research has paid most attention to preventable 
procedures etiologically related to endocarditis, such as 
intravenous drug use, dental procedures, or surgery. 
Hospital-related bacteremia is a well known cause of 
endocarditis, and about 10-30% of all cases of endo- 
carditis are considered to be nosocomial. When endo- 
carditis cases related to cardiac surgery are excluded (to 
some extent, early-onset prosthetic valve endocarditis 
may be considered hospital-acquired), intravascular 
devices are the most important source of bacteremia 
resulting in endocarditis. 
Endocarditis has been reported in association with 
peripheral catheters, central venous catheters and 
monitoring devices, and it has been more commonly 
found involving the aortic and mitral valves. Right- 
sided endocarditis is very infrequent in nosocomial 
endocarditis, in contrast to intravenous drug abusers, 
probably due to the integrity of the endothelium in 
non-addicts. The clinical features of nosocomial endo- 
carditis are not different from community-acquired 
disease, but early diagnosis can be difficult due to 
manifestations of the underlying disease [94]. 
Most reported cases of nosocomial endocarditis are 
caused by Gram-positive bacteria, and the patients with 
the highest risk of infection are those with prosthetic 
valves [95]. The attack rate of prosthetic valve endo- 
carditis resulting from nosocomial bacteremia was 
studied by Fang et al. in a prospective multicenter study 
1961. Of  171 patients with prosthetic valves and 
nosoconllal bacteremia, 18 (1 1%) developed endocardtis 
a mean of 45 days after bacteremia was discovered. In 
six of the cases bacteremia was secondary to intra- 
vascular devices. S. atireus and S. epidermidis were the 
most common organisms isolated. Surprisingly, the 
authors did not find any association between duration 
of antibiotic therapy and subsequent development of 
endocarditis. 
Kecent series on hospital-acquired endocarditis 
also record the importance of intravascular devices in 
this complication (Table 5). Fernindez-Guerrero et al. 
[97] reported 33 episodes of nosocomial endocarditis 
(9.3% of all cases of endocarditis). Intravenous catheters 
were the source ofinfection in I 3  ofthem (56.5%), and 
more than half of the cases were due to S. U I I ~ ~ M S .  
Overall mortality rate was 56%. In the series of 
Tarpenning et al. 72 episodes of nosoconiial endo- 
carditis are described, corresponding to 14.3% of the 
total endocarditis cases seen in that period [98]. S. 
aureiis and S. epiderwlidir were responsible for 17 of the 
cases. Intravascular catheters were the source of 
bacteremia in ten cases, and the overall mortality rate 
was 40.9%. Chen et al. 1991 reported 30 episodes of 
nosocomial endocarditis from a single institution, 
representing 17% of all endocarditis cases. Tricuspid 
valve involvement occurred in three patients (10%). and 
five (17%) had prosthetic valves. S. aiireiis was respon- 
sible for 17 (57%) of the cases. The overall mortality 
was 40%, and was higher (without statistical sig- 
nificance) in those patients aged more than 60 years. 
More than half of the patients in the three series 
were over 60 years of age, reflecting the role of 
degenerative valvular disease in this growing popula- 
tion. Enterococcal endocarditis is more likely to follow 
community-acquired bacteremia as compared to noso- 
coniial disease [ 1001, and indwelling bladder catheters, 
and genitourinary and gastrointestinal conditions are 
more frequently associated rather than intravascular 
devices. Another important cause of nosocorriial endo- 
carditis is Carzdida [loll .  The incidence of candidernia 
has increased in the last two decades, and patients with 
predisposing cardiac lesions or prosthetic valves are at  
high risk of this severe complication. 
Improved care of intravascular devices, antibiotic 
prophylaxis when indicated, and proper treatment of 
unconiplicated catheter-related bacteremia niight 
prevent most cases of nosocomial endocarditis [96]. 
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